ABSTRACT. Ten children with end stage renal disease on chronic hemofiltration (HF) were studied for a 1-yr period to evaluate the efficacy of 1,25-dihydroxyvitamin-D3(1,25(OH)2D3) therapy on biohumoral parameters of renal osteodystrophy and bone mineral content. In six of these children an acute study was done of the direct effect of the H F procedure on calcium and phosphate balance during 12 H F sessions. During the first 6 months of the study all children were treated with 1,25(OH)zD3 (0.25-0.50 pg/ day) to maintain plasma calcium at 9.5-1 1.0 mg/dl. There was a significant increase in plasma calcium ( p < 0.05) and a significant decrease in plasma phosphate ( p < 0.01) and alkaline phosphatase concentrations ( p < 0.05). The circulating levels of NH2 immunoreactive parathyroid hormone did not change, remaining at the upper limits of reference values. Immunoreactive parathyroid hormone-COOH terminal fragment levels decreased significantly (p < 0.05). Bone mineral content rose significantly ( p < 0.01).During the last 6 months of the study, to evaluate the possibility that H F alone might control secondary hyperparathyroidism, 1,25(OH)2D3 treatment was discontinued in five children; plasma calcium and phosphate were well controlled whereas hyperparathyroidism worsened in all five, and one also developed intense pruritus and hypertension. The other five children remained on 1,25(OH)2D3 treatment; two of these were transplanted, and the other three continued to show an improvement of mineral balance. The results of the acute study showed that calcium balance was positive with a mean Ca++ gain of 140 mg/HF session. The mean total phosphate removed per H F run was 574 mg. We conclude that even though a calcium gain and a high phosphate removal was obtained with our H F prescription, secondary hyperparathyroidism in children on chronic H F may be maintainued under control if 1,25(OH)2D3 supplementation is provided. (Pediatr Res 20: 5-8,1986 There are many reports of long-term 1,25(OH)2D3 treatment of children with ESRD with and without chronic HD or chronic ambulatory peritoneal dialysis (1-7). However, there has been no study of such treatment in children on chronic HF, a replacement method based on convective transport (8) recently introduced in children (9). This method has been reported to be more effective than HD in removing toxins of middle and large molecular weight (10) and in reducing hypotension and other symptoms of dialysis intolerance in uremic adults and children (9, 1 1-13). HF has been variously claimed to improve (l3), worsen (14), or not change (15) hyperparathyroidism in uremic adults. Such discrepancies may be explained by differences both in vitamin D supplementation and in calcium balance during the HF procedure. The aim of the present study was to investigate the effect of 1,25(OH)2D3 treatment on the most important biohumoral parameters of renal osteodystrophy and BMC in 10 children on chronic HF. In addition, we evaluated mineral metabolism in five of these children on HF without vitamin ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.